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Abstract  
Objectives: To establish older women's (≥75 years) information preferences 
regarding two breast cancer treatment options: surgery plus adjuvant endocrine 
therapy versus primary endocrine therapy (PET). To quantify women's preferences 
for the mode of information presentation and decision making (DM) style. 
Methods: This was a UK multi-centre survey of women, ≥75 years, who had been 
offered a choice between PET and surgery at diagnosis of breast cancer. A 
questionnaire was developed including two validated scales of decision regret and 
DM preferences.  
Results: Questionnaires were sent to 247 women and 101 were returned (response 
rate 41%).  The median age of participants was 82 (range 75 to 99), with 58 having 
had surgery and 37 having PET. Practical details about the impact, safety and 
efficacy of treatment were of most interest to participants.  Of least interest were 
cosmetic outcomes after surgery. Information provided verbally by doctors and 
nurses, supported by booklets, was preferred. There was little interest in technology 
based sources of information. There was equal preference for a patient-centred or 
doctor-centred DM style and lower preference for a shared DM style. The majority 
(74%) experienced their preferred DM style.  Levels of decision regret were low 
(15.73, scale 0-100).  
Conclusions: Women strongly preferred face to face information.  Written formats 
were also helpful, but not computer based resources. Information that was found 
helpful to women in the DM process was identified.  The study demonstrates many 
women achieved their preferred DM style, with a preference for involvement, and 
expressed low levels of decision regret.   
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Introduction 
A third of new breast cancer diagnoses occur in women aged over 70 years in the 
UK. Across all age ranges survival rates have improved with a fall in mortality of 37% 
since 1971 [1].  However, improvement in survival rates in older women (>70 years 
of age) is lower than in younger women [2]. Older women are less likely to receive 
standard treatment; with rates of primary surgery, adjuvant radiotherapy and 
chemotherapy all lower [2-4].  
Current UK guidelines [5] state that primary endocrine therapy (PET) should only be 
offered if “significant comorbidity precludes surgery” and that age alone should not 
affect the decision [5]. However, PET continues to be widely used in the UK as an 
alternative to surgery with PET used in up to 40% of women over 70, compared with 
less than 6% in women under 70 [6]. Increasing age, being deemed too frail or unfit 
for surgery are cited as reasons for older women receiving non-standard treatment 
such as PET [3, 4]. Patient choice is also identified as a factor in women receiving 
PET instead of standard surgical treatment. Oncologic outcomes with PET are 
acceptable, but rates of local control are inferior to surgery and there may be a small 
reduction in breast cancer specific survival [7, 8].  This needs to be balanced against 
short term morbidity associated with surgery.  Weighing such ‘trade offs’ is complex, 
requiring adequate information about each option and its consequences [9]. 
There is little research investigating information needs of older women or their 
preferred level of involvement in decision making (DM) about treatment options [10]. 
Currently, there are no resources to support women faced with a choice between 
surgery plus adjuvant endocrine therapy (hereafter referred to as 'surgery') and PET 
for early breast cancer. This study (nested within a current NIHR study 'Bridging the 
Age Gap'’ [11]) aimed to identify the information needs and preferences among 
women age ≥75 offered a choice between PET and surgery at diagnosis for breast 
cancer. Previously reported qualitative findings [9, 12] were used to develop the 
content of a questionnaire and to illuminate its analysis. The main aim of the 
questionnaire was to further establish older women's preferences regarding receiving 
information about breast cancer treatment options (surgery or PET) and quantify 
issues raised in the interview study [9]. A secondary aim was to quantify women's 
preferences regarding the presentation of information and establish their preferred 
DM styles.  
Study Design 
This was a retrospective, cross-sectional, survey of women aged ≥75 years who had 
been offered a choice between PET and surgery at diagnosis for breast cancer within 
the previous five years. Those with locally advanced or metastatic breast cancer or 
who lacked cognitive capacity to consent were excluded.  
Questionnaire development [13] was based on: findings from a literature review [14], 
expert opinion within the research team, the input of a local patient group [15] and 
previous qualitative interviews [9]. The questionnaire collected data on the 
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information women had found helpful during their treatment DM, on information they 
would ideally prefer, its preferred format and source, and on the women's preferred 
and actual DM styles. There were a total of 57 questions split into five sections.  
1) Patient demographics, (4 items).  
2) Information needs prior to treatment decision, (30 items).  
3) The process of treatment DM, including the Control Preferences Scale [16], (7 
items).  
4) Optimal DM, including the Decision Regret Scale [17], (10 items). 
5) Preferred format, media and presentation of information, (9 items). 
A combination of categorical responses and Likert scales were used for the majority 
of the questions. In addition there were four open response questions. 
The questionnaire was piloted by the full study team which included five members of 
a local cancer patient support group and subsequently adapted according to their 
feedback to maximise content and face validity, clarity, comprehensibility, 
acceptability and presentation [18]. Due to the absence of related validated 
questionnaires, criterion validity was not assessed. As the questionnaire did not 
measure any abstract concepts, such as pain, construct validity was not assessed.  
Sample size 
Eligibility criteria included women newly diagnosed with breast cancer within the 
previous five years who had a treatment choice documented in their medical notes.  
The study population was drawn from 10 breast cancer units. This was a convenience 
sample from units which were stratified on the basis of high and low rates of surgery 
and PET. Each unit has a yearly average of 300 newly diagnosed women.  Of these, 
approximately 25% will be over 75 years, and 85% of these will have ER+ cancers, 
equating to 64 eligible women per unit per year, or 3200 women in total.  Based on 
this population size, a random sample of 344 enables estimation of proportions to 
within a maximum of ±5% with 95% confidence.   
Ethics Approval 
National Research Ethics Committee approval and local research governance 
approval was obtained.  
Recruitment 
Eligible women were identified by healthcare professionals (HCPs) in 10 NHS breast 
units across England and Wales. Women were offered a pack, including a letter 
inviting participation, an information sheet, a questionnaire and a freepost envelope 
for return. Consent was implied by the return of the questionnaire.  Study recruitment 
commenced November 2013 and ended 31st January 2015. 
Data Analysis 
4 
 
Statistical analysis was completed using SPSS V23 and the 'R' Stats Package. 
Analysis was primarily descriptive. Categorical data were presented as frequencies 
and percentages. Fisher's Exact test was used to identify associations between 
preferences and age, treatment received and level of education. (Only associations 
with age are reported in this paper.) In line with convention the five statements in the 
patients’ preferred and achieved style DM tool were collapsed into three categories; 
doctor-centred (passive), shared (collaborative) and patient-centred (active) DM. The 
decision regret scale score was calculated using the developer's formula [18] (See 
Table 1). Data were entered by a single person and then checked and cleaned by a 
second.  
Results 
Two hundred and forty-seven women were offered a questionnaire and 101 were 
returned (41% response rate). Twenty-nine (29%) were in the 75-79 age group, 32 
(32%) in the 80-84 age group, 22 (22%) in the 85-89 age group, 17 (17%) in the 90+ 
age group and one unknown (median age 82 years, range 75 – 99 years). Fifty-eight 
(57%) women received surgery and endocrine therapy, 37 (37%) received PET and 
six (6%) unknown. Seventy-six (75%) women left school at or before age 16, five 
(5%) left school at 18, 19 (19%) attended college or university and one unknown.  
Information needs to support decision making  
Women were asked to identify information that had been helpful in making a 
treatment decision (Figures 1a & 1b). Across all ages, information about the need for 
further treatment and how long tablets should be taken for were most frequently cited, 
58/73 (79%) and 58/74 (78%) respectively. Items scoring lowest across all ages 
related to cosmetic outcomes, specifically: how the scar would look after surgery, 
7/60 (12%), and whether they would look different after surgery 11/60 (18%).  Less 
than half (28/63, 44%) of the women had found information about post treatment 
independence helpful. The helpfulness of information about cure rates with PET 
increased with age (Fisher’s Exact p=.005). In the 75-79 age group 6/17 (35%) found 
the information helpful, 5/21 (24%) in those 80-84, 12/17 (71%) in those 85-89 and 
9/11 (82%) in those 90+.    
 
Source and format of preferred information 
Actual information sources used by women to make treatment decisions  
Additional to the information given verbally by doctors and nurses, leaflets and 
booklets provided by the hospital were considered helpful forms of information 
(57/101, 56%) by most women. Discussion with the GP (43/101, 43%), and family 
and friends (37/101, 37%) were also helpful. Only 6/101 (6%) reported using the 
internet. Sources that required reading information i.e. leaflets, booklets, magazines 
and on-line materials, showed a decreasing preference with age (Fisher’s Exact 
p=.007). When asked if enough information to make a treatment decision was 
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provided, 79/91 (86%) said it was, whilst a small number, 13/91 (14%) all under 90, 
would have liked more.  
Ideal information sources  
Face to face discussion with the doctors in the breast clinic was the preferred 
information source (81/100, 81%) followed by a nurse (37/101, 37%) then a booklet 
or leaflet (33/101, 33%). Of least interest were DVDs or videos, (6/100, 6%) and 
internet based information (2/100, 2%). Only 5/100 (5%) did not want any information. 
Level of access to the internet was generally poor with only 27/93 (29%) patients 
owning their own computer and having internet access. 23/93 (25%) had no access 
to the internet, 21/93 (23%) could access the internet via others and 22/93 (24%) said 
they did not want to use the internet. When asked about the likelihood of future use 
of internet based information 57/88 (65%) responded that they were ‘very unlikely’ or 
‘somewhat unlikely’ to use it for information related to breast cancer whilst 21/88 
(23%) stated they were ‘likely’ or ‘somewhat likely’ to use it. Ten (11%) were unsure. 
However, of the 17 surgery related items a median of 3 (range 0-14) were deemed 
to be useful. Of the seven tablet related items a median of 3 (0-7) were deemed 
helpful.  
Ideal information formats 
The preferred format of written information regarding treatment risks and benefits 
across all ages was a statement in words (e.g. “breast cancer is common in women 
in the UK”) (51/101), followed by proportion e.g. "1 in 8 women in the UK will get 
breast cancer". There was little interest in visual displays with only 11/101 preferring 
a pictogram, 10/101 a pie chart, and 9/101 a bar chart.  
Preferred support during the decision making process  
One eligibility criterion for the study was the women having received a documented 
treatment choice. However, more than half recalled being offered only one option 
52/93 (56%) either only surgery or only PET, and only 40% (37/93) recalled being 
offered a choice.   
Preference for a patient-centred (36/93, 39%) and a doctor-centred DM style (35/93, 
38%) was fairly evenly split, with fewer preferring a shared DM style 22/96, (24%). 
There was a significant association between ideal and actual DM style (Fisher’s Exact 
p<0.001) with 69/93 (74.2%) achieving their preferred DM style (Table 2). There was 
also a strong association between patient-centred actual DM and PET and between 
doctor-centred DM and surgery (Fisher’s Exact, p>0.001).  
The majority of women stated that ideally their doctor (76/82, 93%) or breast care 
nurse, (45/55, 82%) would be the person to discuss their treatment decision with. A 
number of women (41/46, 89%) also felt leaflets would be helpful in making their 
treatment decision. There was a negative association with age for preference for 
written leaflets (Fisher’s Exact, p>0.007). Friends and family were reported to be 
helpful for 34/47 women (72%). 
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Decision regret  
The mean score of the Decision Regret Scale was 14.48 (scale 0-100, SD 18.60, 
range 0-100) demonstrating a low level of regret.   
Discussion 
This study has identified the information and DM support needs of older women with 
breast cancer facing a choice between surgery or PET. 
The strong preference was for face to face discussion with a doctor (most preferred) 
or nurse when making a treatment decision.  Booklets or leaflets were considered the 
most useful after the face to face consultations. These findings reflect our previous 
qualitative findings [9]. In line with the findings from Husain and colleagues it is 
feasible that the women were not only gaining information from the face to face 
discussions but also looking for any obvious or subtle clues as to what treatments 
they felt the doctor was 'recommending'.  The women were reluctant to access breast 
cancer related information via technology, which is in contrast to younger women who 
increasingly seek information via the internet [19]. Previous studies in this age group 
have identified feeling too old, fear of technology, lack of skills, no interest in 
technology and no access to the internet [20, 21] as being potential reasons for this.  
Presenting numerical information visually e.g. pie charts, was substantially less 
preferred than using words, reinforcing the findings of our qualitative study. Visual 
displays are particularly beneficial to people with lower numeracy skills provided they 
are able to understand graphical representations [22].   Older people found visual 
displays less helpful and sometimes confusing for those with low levels of both 
numeracy and graph literacy [22].  The evidence of a link between declining 
numeracy, lower literacy [23] and increasing age, and the desire to conserve time 
and energy, [24] may explain the strong preference for the more familiar use of words. 
This strong preference is of some concern as it may lead to inaccurate risk perception 
[25].  
The most surprising finding was the limited preference for information regarding the 
effect of treatment on the women’s independence level. This is in contrast to other 
studies, including our previous interview study [9], that have shown the impact on 
independence and quality of life were key considerations [16, 26]. However, over a 
third of respondents (38%) did not answer the two questionnaire items related to 
these, which could partly explain this finding. It is possible this is as a result of the 
wording of the questions which states "…after my operation." that led women who 
received PET to dismiss this question as at the time of completion it seemed 
irrelevant to them.  
The amount of information older women require to make a treatment decision is 
variable. Some older patients find the type and amount of medical information 
overwhelming [27], and are reported to express fewer information needs [28, 29] 
whilst others want as much information as possible [20].  
7 
 
Also reported is variance in the role women wish to play in DM. Some studies report 
that older women are often passive in the DM process, relying on HCPs to make 
treatment decisions [30, 31], whilst other studies report that older women want a more 
active role  [12, 32-34].  
Four studies examine DM where women are faced with a choice of PET or surgery 
followed by endocrine therapy [9, 10, 12, 35].  Husain et al [10] reported heavy 
reliance on expert medical advice when making a treatment choice. In more recent 
studies [9,12] women were eager to demonstrate their involvement and how they 
made the decision but were also keen to gain approval of their choice demonstrated 
by statements such as 'the doctor seemed pleased with my choice' [9]. Morgan and 
Burton et al [35] explored the balance of input of clinicians and patients into the DM 
process and reported that whilst there was variability in the DM styles, many older 
women achieved their treatment preferences.  
Ensuring women receive the preferred level and amount of information as well as 
involvement when making treatment decisions can be a challenge for clinicians. 
Decision support tools of varying length and detail may therefore help patients reach 
their preferred level of information and involvement in decision making [12]. The 
findings from this study will contribute to the development of decision support 
interventions specifically for women ≥70 years, faced with a treatment choice of 
surgery or PET.  
A number of women reported not being offered a choice of treatments. This could be 
a problem of recall or the lack of clarity about what constitutes being offered a choice 
which has been previously reported [36]. During the consultation it may be that two 
treatments were discussed which HCPs deemed to be an offer, but that there was an 
emphasis on one and the other was merely mentioned [12]. It could also mean that 
having made up their mind about the treatment they wanted prior to the consultation 
women simply filtered out information they felt was irrelevant.  
Where more communication between surgeons and women occurs, choice is 
perceived to be greater [37]. However, when asked about their involvement in 
treatment DM the findings from both our interview and questionnaire studies found 
women consistently reporting involvement [9, 12]. It would seem that women are 
differentiating between the offer of a choice of treatment and involvement in treatment 
DM. This could indicate there is a need for HCPs to make the offer of a choice much 
more overtly.   
Study Limitations 
The declining cognitive ability and memory function of older people [38] may impact 
on reliability of findings in a retrospective questionnaire of this kind. However, the 
diagnosis and treatment for breast cancer is a significant event, and as such is 
arguably likely to produce strong memories. Time after the event is also a useful 
period of reflection and provides a space for making sense of the situation. However, 
it is acknowledged that for some of the women the time period since breast cancer 
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treatment was significant (up to 5 years) and the details of information received and 
used, and the DM process, may be difficult to recall. 
The achieved sample size was low for statistical representation of the population and 
the low completion rate further impacted on the validity of the results so the findings 
should be used with caution. However, despite the sample size not achieving its 
target, the study provided evidence supporting our interview findings [9]. Previous 
studies with this population of women have closed early due to inadequate 
recruitment [39].  Recruitment to this study was reliant on HCPs in NHS breast units 
with the questionnaires being anonymously completed. The researchers, therefore, 
had no access to patient details to enable reminders to be sent to non-responders. 
Although the questionnaire was rigorously developed, it would seem that for some of 
this older population completion proved to be a challenging process.  We can only 
speculate that the length of the questionnaire and/or the content were issues that 
contributed to the amount of missing data. The present study has provided a great 
deal of information about the appropriateness of postal, self-completion 
questionnaires with women who report a lack of interest in reading.  
Conclusion 
The findings of this study demonstrate that the majority of women achieved their 
preferred decision making style and expressed low levels of decision regret. They 
also challenge the notion that older women prefer a passive role in DM. The 
findings highlight that the preferred way to receive information is via face to face 
communication, supplemented by uncomplicated written information and there is a 
reluctance to engage with technology to obtain information. The development of 
decision support tools for women with older women facing a treatment choice of 
surgery or PET may enhance the quality and consistency of the information 
provided and encourage participation (to individuals’ preferred level) in the DM 
process. 
Clinical Implications 
Items of information were identified that women found useful in making their 
decision that will be of value to HCPs in supporting women through the DM process 
as well as informative in the development of information and breast cancer decision 
support tools for older women.  
 
The authors have no conflict of interest to declare. 
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 Table 1 
 
 
  
 Preferred Decision-Making 
Style 
 
Actual Decision-Making Style DM 
Classification 
1 I prefer to make the final decision 
about which treatment I have  
I made the final selection about 
which treatment I had Patient-centred 
DM 
 
2 I prefer to make the final 
selection of my treatment after 
seriously considering my 
doctor/nurse’s opinion 
I made the final selection of my 
treatment after I had seriously 
considered my doctor/nurse’s 
opinion 
3 I prefer that my doctor/nurse and 
I share the responsibility for 
deciding which treatment is best 
for me 
My doctor/nurse and I shared 
the responsibility for deciding 
which treatment was best for me Shared DM 
4 I prefer that my doctor/nurse 
makes the final decision about 
which treatment will be used, but 
seriously consider my opinion 
My doctor/nurse made the final 
decision about which treatment 
was used, but seriously 
considered my opinion 
Doctor-centred 
DM 
 5 I prefer to leave all the decisions 
regarding my treatment to my 
doctor/nurse 
My doctor/nurse made all the 
decisions regarding my 
treatment 
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Table 2. Congruence between women’s preferred and actual decision making 
style 
No. of patients Actual DM Style  
Preferred DM 
Style 
Doctor-
centred 
Shared Patient-centred Total 
Doctor-centred 31 1 3 35 
Shared 7 9 6 22 
Patient-centred 4 3 29 36 
Total 42 13 38 93 
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what the scar from the operation would look like (N=60)
about possible support for my loved ones while I was in hospital (N=59)
if I would look different after the operation (N=60)
if I would need extra help at home after the operation (N=58)
if I would have pain after the operation (N=62)
the likelihood of cure if I just had the operation (N=59)
if I could be asleep or awake for the operation (N=62)
about what might happen after a general anaesthetic (N=65)
if I would have the same level of independence after the operation (N=63)
about the sort of pain relief I could have (N=64)
the likelihood of cure if I had the operation and tablet treatment (N=63)
about the side effects of the operation (N=66)
whether my family/friends could look after me after the operation (N=65)
about any possible complications or side effects of the operation (N=69)
how safe the operation would be for me to have at my age (N=75)
if I needed to have my breast removed or could just have the lump removed (N=73)
how long I would be in hospital if I had an operation (N=75)
Yes No Unsure NA
Figure 1a. Information women found helpful when deciding between PET and surgery 
(Surgery information)
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how long I would have to take the tablets for (N=74)
if I would need any further treatment(N=73)
about the side effects of the tablets (N=67)
about the likelihood of the cancer coming back (N=64)
how I would get the tablets(N=63)
how effective the treatments have been for others(N=65)
the likelihood of cure if I just had tablet treatment (N=66)
Figure 1b Information women found helpful when deciding between PET and surgery 
(Tablet information) 
Yes No Unsure NA
Ite
m
s  
of
  i
nf
or
m
at
io
n 
 w
om
en
  w
an
te
d 
to
 k
no
w
Number of women
